©The Author(s) 2026.
World J Gastroenterol. Jan 21, 2026; 32(3): 113187
Published online Jan 21, 2026. doi: 10.3748/wjg.v32.i3.113187
Published online Jan 21, 2026. doi: 10.3748/wjg.v32.i3.113187
Table 1 Analysis of clinical data of patients with chronic liver diseases
| Group | n | Male/female | Age (years) | HBsAg (+/-) | AFP (ng/mL) | Child-Pugh | ||||
| ≤ 20 | 21-399 | ≥ 400 | A | B | C | |||||
| NC | 111 | 57/56 | 22-79 | 0/111 | 111 | 0 | 0 | - | - | - |
| CH | 72 | 55/17 | 23-75 | 72/0 | 55 | 17 | 0 | - | - | - |
| LC | 60 | 40/20 | 32-88 | 60/0 | 42 | 17 | 1 | 48 | 9 | 3 |
| HCC | 129 | 93/36 | 37-86 | 97/32 | 38 | 53 | 38 | 97 | 23 | 9 |
- Citation: Cai Y, Liu LY, Xia XX, Tang H, Xu M, Sai WL, Yao DF, Yao M. Stemness CD24 activation promotes hepatocellular carcinoma progression via an immune escape mechanism. World J Gastroenterol 2026; 32(3): 113187
- URL: https://www.wjgnet.com/1007-9327/full/v32/i3/113187.htm
- DOI: https://dx.doi.org/10.3748/wjg.v32.i3.113187